about
Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritisExtracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-β1 and EMMPRINEMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure.Clathrin-independent endocytosis: a cargo-centric viewEMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.Epitope mapping of metuximab on CD147 using phage display and molecular docking.Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne DiseasesEMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomasEMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesteroneCyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments.Titanium dioxide nanoparticles induce matrix metalloprotease 1 in human pulmonary fibroblasts partly via an interleukin-1β-dependent mechanism.Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland.Increased expression of EMMPRIN and VEGF in the rat brain after gamma irradiationEMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease.Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation.Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications.Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.Differential protein profiling of renal cell carcinoma urinary exosomes.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.Spatiotemporal expression of caveolin-1 and EMMPRIN during mouse tooth development.Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats.
P2860
Q26850781-C113657C-8757-4238-AA36-8F616FF5E1B3Q28535041-7D961BDF-B010-4A97-BD1D-1AB6B1642199Q33687242-D8AF09BA-2070-443E-AB22-ACB57A850E1DQ34034976-DEBBFBBA-45CF-4A34-B0A0-879FA9462C28Q34149489-12E65692-ADEC-4027-9893-D7D9CA6A3F56Q34591446-C37F3F61-40A6-491A-94FE-286E440A1EA1Q34629446-865A1C45-F1F7-4ACF-BB8D-7E9ADF498D44Q34825106-DCF3D06A-A838-4D83-B368-49087F3DB196Q35598662-71264224-5132-434F-92A3-4FAD261FD989Q35833138-00B5B65A-C043-4B1C-B00F-AD846C865426Q36038630-BD7B9213-B3E3-42F5-A55E-8899B62AA8EAQ37266269-33807AC1-C3D1-4D7C-B10A-D2C9332D7055Q37719732-9B838CB8-2279-4F57-B204-F8DF8619C248Q38899542-9FB741D5-E792-4AFE-A4B9-E650C21A0826Q38985433-A1A04FA8-6DF8-4245-B546-0FD567DC9E1EQ38994594-30EB30AC-8027-4E1E-AAFA-647987AB2A07Q39226247-83A6C3EF-3974-4ADD-8A38-85DA856BDF2FQ39328629-688C35A1-67FC-41CA-9021-FD9FF408D05CQ39374878-28CEA1B2-0515-4DE6-9ADF-EA80BC164D3AQ41064508-7AF7B385-D410-4971-B7D9-53C76877ED87Q41554254-D64BEF38-2556-4BD9-9CA3-756C7D0ED8C6Q41980966-EBD56A61-0F63-42CC-9B76-820CEBAD9F42Q41989140-8B8EC759-033E-422F-BBDD-3BCAAF5E5852Q42920120-CEB4C8BD-F60C-4777-B69E-723637B0815FQ44578756-FEA704E2-A972-4078-8475-10FB39A37F04Q44639478-D5AD773F-6DD0-4F58-8477-E3C3A1D30314Q46342648-8C62DFA7-0815-4AB5-A81D-9B5BA346D461Q47223491-E77B5398-ADC6-438E-9CED-EE904E33ADBEQ50520505-AF310956-CFCF-4651-BF90-5E1A1B016A5FQ53027850-3E0268C8-0ED2-4C3E-ADE2-04C286A7B868
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of emmprin/CD147 in tissue remodeling.
@en
Role of emmprin/CD147 in tissue remodeling.
@nl
type
label
Role of emmprin/CD147 in tissue remodeling.
@en
Role of emmprin/CD147 in tissue remodeling.
@nl
prefLabel
Role of emmprin/CD147 in tissue remodeling.
@en
Role of emmprin/CD147 in tissue remodeling.
@nl
P2093
P2860
P1476
Role of emmprin/CD147 in tissue remodeling
@en
P2093
Eric E Gabison
Samia Mourah
Suzanne Menashi
P2860
P304
P356
10.1080/03008200802151722
P50
P577
2008-01-01T00:00:00Z